hydroxyurea has been researched along with Hormone-Dependent Neoplasms in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Using pharmacokinetic data obtained during the course of a clinical trial of hydroxyurea, we simulated a dosing regimen that would sustain plasma drug concentrations above 100 microM for 120 h (1 g loading dose, followed by 500 mg every 6 h for 5 days in a 70 kg man)." | 1.29 | In vitro antitumor effect of hydroxyurea on hormone-refractory prostate cancer cells and its potentiation by phenylbutyrate. ( Cooper, MR; Figg, WD; McCall, NA; Myers, CE; Samid, D; Sartor, O; Thibault, A; Walls, RG, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Figg, WD | 1 |
| Walls, RG | 1 |
| Cooper, MR | 1 |
| Thibault, A | 1 |
| Sartor, O | 1 |
| McCall, NA | 1 |
| Myers, CE | 1 |
| Samid, D | 1 |
1 other study available for hydroxyurea and Hormone-Dependent Neoplasms
| Article | Year |
|---|---|
In vitro antitumor effect of hydroxyurea on hormone-refractory prostate cancer cells and its potentiation by phenylbutyrate.
Topics: Cell Division; Cell Survival; Drug Synergism; Hormones; Humans; Hydroxyurea; Kinetics; Male; Models, | 1994 |